Señales en vivo de APEN | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 abr 2023 @ 16:00):

Stats
Volumen de hoy	1.64M
Volumen promedio	1.33M
Capitalización de mercado	579.72M
EPS	$0 ( 2024-03-28 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-9.43
ATR14	$0.0390 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-04	Mcgaughy R Kent Jr	Sell	400 675	Common Stock
2023-04-04	Mcgaughy R Kent Jr	Sell	38 667	Stock Option (Right to Buy)
2023-04-04	Cpmg Inc	Sell	400 675	Common Stock
2023-04-04	Barr John R	Sell	44 082	Common Stock
2023-04-04	Barr John R	Sell	5 271	Non-Qualified Stock Option (right to buy)

INSIDER POWER
-16.45
Last 98 transactions
Buy: 5 638 377 \| Sell: 4 907 735

Volumen Correlación

Largo: 0.13 (neutral)

Corto: 0.00 (neutral)

Signal:(66.037) Neutral

Apollo Endosurgery Inc Correlación

10 Correlaciones Más Positivas
NETE	0.955
MDGL	0.952
RAVN	0.922
SRAC	0.9
UFPT	0.886
AGYS	0.883
NRIM	0.882
PODD	0.879
TSBK	0.879
AMRB	0.875

10 Correlaciones Más Negativas
BVXV	-0.948
SNPX	-0.938
SVAC	-0.935
FREQ	-0.934
PAIC	-0.933
SVOK	-0.928
TSP	-0.923
ALTM	-0.922
ZI	-0.919
SGRP	-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Apollo Endosurgery Inc Correlación - Moneda/Commodity

0.33
( neutral )

0.47
( neutral )

-0.30
( neutral )

0.41
( neutral )

-0.29
( neutral )

Apollo Endosurgery Inc Finanzas

Annual	2022
Ingresos:	$76.86M
Beneficio Bruto:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2022
Ingresos:	$76.86M
Beneficio Bruto:	$42.43M (55.20 %)
EPS:	$-0.980

FY	2021
Ingresos:	$62.99M
Beneficio Bruto:	$34.96M (55.50 %)
EPS:	$-0.820

FY	2020
Ingresos:	$42.05M
Beneficio Bruto:	$22.24M (52.90 %)
EPS:	$-0.990

Financial Reports:

No articles found.

Apollo Endosurgery Inc

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.